MSF Science Portal
My saved items
Conference Material > Slide Presentation
Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial
Fahal AH,
Ahmed ES,
Bakhiet SM,
Bakheet OE,
Fahal LA,
Mohamed AA,
Mohhamedelamin ESW,
Bahar ME,
Attalla HY,
Siddig EE,
Mahmoud NA,
Musa AM,
van de Sande WWJ,
Scherrer B,
Oyieko P,
Egondi T,
Onyango K,
Hata K,
Chu WY,
Dorlo TPC,
Nyaoke BA,
Strub-Wourgaft N,
Zijlstra EE
Download
View
Share
Linked Items
Share
Download
No Abstract Available
Countries
Sudan
DOI
10.57740/YDzkQTI
Published Date
16-May-2024
Languages
English
Conference
MSF Scientific Day International 2024
Linked Items
Conference Material > Abstract
Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial
16-May-2024
